Tags » Systemic Lupus Erythematosus

CEP 33779

CEP-33779, CEP33779
CAS 1257704-57-6
Chemical Formula: C24H26N6O2S
Molecular Weight: 462.57
Elemental Analysis: C, 62.32; H, 5.67; N, 18.17; O, 6.92; S, 6.93


PRECLINICAL Treatment of Rheumatoid Arthritis, Agents for Colorectal Cancer Therapy Systemic Lupus Erythematosus, 2,807 more words

Preclinical Drugs

ACR/ARHP 2016: Study Addresses Possible Impact of H.P. Acthar® Gel on Use of Corticosteroids Among Patients with Rheumatoid Arthritis, Lupus, and Dermatomyositis/Polymyositis

CHESTERFIELD, United Kingdom,  Mallinckrodt plc  presented on Nov. 17, 2016, results of a retrospective, claims-based analysis that indicated the use of H.P. Acthar® Gel (repository corticotropin injection) may be associated with reductions in corticosteroid (CS) requirements among patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and dermatomyositis and polymyositis (DM/PM). 976 more words

Scientific Sessions

Spinning right out of control

As weekends go, the last one wasn’t really the best.  Actually, it was probably one of the worst, in the grand scale of things.  Recent bugs… 593 more words

What Is Lupus

Systemic Lupus Erythematosus Clinical Review, Industry Study, Market Research and Forecast 2016 - 2020

The Market research comprehensive data on Systemic Lupus Erythematosus Market Product Pipeline Review, 2016, is well organized and easily readable. This group is engage in a wide range of other fields and businesses like report generation, R&D, development of innovative drugs and others. 298 more words


As We Are Interview

My wonderful friend and Founder of As We Are, Zoya Jiwa, asked me to do an interview and photo shoot for her foundation. For those who don’t know,  1,247 more words

Coexistence of psoriasis and systemic lupus erythematosus

Varada S, et al. Treatment of coexistent psoriasis and lupus erythematosus. J Am Acad Dermatol. 2015 Feb;72(2):253-60.

  • The coexistence of psoriasis with lupus erythematosus is rare and presents a therapeutic challenge.
  • 501 more words

The fickle nature of disease: is it hampering our treatments?

As medicine becomes more complex and the dictionaries of disease become libraries, it’s time for us to change our clinical language. We have a duty to explain the complexities of our treatments to payers, patients and communities in the simplest, most understandable and up-to-date way possible. 386 more words